Investment – Medical Alley Association

Investment

Launching a Medtech Product? Have Your Regulatory, IP and Governance Affairs in Order Before Engaging Investors

By Walter Linder, Amy Judge-Prein, and Jonathan Zimmerman Investors in medtech companies are willing to take risks. However, they will expect their investment to be put to effective use with defined objectives, and their diligence will focus on identifying potential impediments to those objectives. Because momentum is important when seeking investment, it is critical that […]

Medical Alley Q3 Investment and Ecosystem Report

Medical Alley is the global epicenter of health innovation and care. Companies that succeed here change the face of healthcare as we know it, building great businesses and powering Minnesota’s economy along the way. This ecosystem is more than just a cradle for early-stage companies or the sole domain of established market-leaders, it is a […]

In the Know: Healthcare News for October 7, 2019

New M Health Fairview Brand Launches Cantel Medical closes Hu-Friedy buy University of Minnesota to test cancer-fighting ‘natural killer’ cells The Many Faces of Value-Based Healthcare Ecolab buys Australia’s Gallay Medical & Scientific U.S. Department of Defense Awards $6 Million to Humanetics Corporation for Advanced Development of Radioprotectant Late-Breaking Data Shows Abbott’s MitraClip is Cost […]

Despite a Cold M&A Market in Minnesota, Deal Activity in Healthcare Remains Hot

2019 has not been a banner year for Minnesota’s M&A market. After a half-decade of record-setting activity, the local M&A scene has cooled significantly, with the lowest reported deal volume and dollar values since 2013. According to Pitchbook data, total deal count for Minnesota companies for the first half of 2019 was 35% lower than over […]

POPS! Diabetes Care Announces Closing of Oversubscribed Series A Funding

MINNEAPOLIS–(BUSINESS WIRE)–POPS! Diabetes Care—a revolutionary diabetes care management company—is excited to announce that it has closed an oversubscribed Series A funding round of $6 million USD due to strong investor demand. We are excited to announce that we have closed an oversubscribed Series A funding round of $6 million USD due to strong investor demand! […]

2019 First Half Investment Report

Three Key Takeaways: M&A activity is strong in Medical Alley, with over $15 billion spent in the second quarter alone, as companies large and small look for paths to growth Medical Alley startups brought in $261.6 million dollars in the first half of the year, their second-best mark in the last five years Signs point […]

MAA Member Discount to MedCity INVEST Digital Health Minneapolis

This content is members-only. If your company is a MAA member, then you are a member as well! Please be sure you are logged in and try again. If your company is interested in becoming a member, please click here. If you feel you are a member and having trouble logging in, please contact info@medicalalley.org or 952-542-3077 for assistance.

Reprise Biomedical Raises $12.5 Million and Completes Spin-Off From Miromatrix Medical

New Minnesota-based medical device company focuses on biological medical devices manufactured using perfusion decellularization technology. Minneapolis, Minn. (July 1, 2019) – Reprise Biomedical, Inc., a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology, has successfully completed a $12.5 million private placement and commenced operations as a spin-off from […]

Angel Tax Credit Program Reopens; Medical Alley Applauds Minnesota’s Return to an Early-Stage Growth Agenda

Minneapolis, MN – Medical Alley Association is thrilled to announce that starting July 1, 2019 the Minnesota Department of Employment and Economic Development (DEED) will be accepting applications for the newly-reenacted Angel Tax Credit Program. Medical Alley Association thanks Senator Paul T. Anderson and Representative Carlie Kotyza-Witthuhn for authoring this bill, as well as Governor […]

Up & Running with Brian Brockway, President and CEO of VivaQuant

Brian Brockway is the founder of Data Sciences Intl. (DSI), the leading provider of wireless implantable sensors and systems for preclinical testing of new drugs and biomedical research. He bootstrapped DSI with SBIR grants into a highly profitable business with over $40 million in revenue where he developed domestic and international direct sales and distribution […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER